Misshapen proteins cause a mess of trouble—particularly in neurodegenerative diseases. But a new study suggests it's possible ...

How reorganizing existing drugs and vaccine components can dramatically alter their potency, selectivity, and even their ...

Scientists have created a new way to map how brain cells connect by assigning each neuron a unique molecular “barcode.” Using ...

The firm's lead program is an in vivo CAR T-cell therapy it's developing with its mRNA platform for B-cell mediated autoimmune diseases.

Gene expression analysis helps uncover how cells function, adapt, and contribute to disease. Techniques from microarray preprocessing to advanced single-cell proteomics offer complementary insights ...

AI-guided redesign of protein alphabet in bacteria could unlock new ways to build synthetic organisms.

cDNA is produced from RNA templates via reverse transcription and is used in applications like RT-qPCR, microarrays, and RNA-seq. High-quality synthesis depends on intact RNA, removal of genomic DNA, ...

Abstract: Recent advancements in electrochemical detection have created significant opportunities in biosensing, particularly in medical diagnostics and health monitoring, where real-time response, ...

Abstract: This study focuses on high-grade serous ovarian cancer (HGSOC), one of the most common histological subtypes of epithelial ovarian cancer worldwide, accounting for 75% of all ovarian cancer ...

Applying new analytic methods to nearly 16,000 ancient genomes reveals natural selection has acted on hundreds, not dozens, of genes in West Eurasia over the last 10,000 years. More than half of the ...

Illumina Inc. (NASDAQ:ILMN) is one of the best quality stocks to buy according to hedge funds. On March 18, Illumina and Labcorp (NYSE:LH) announced an expanded collaboration aimed at increasing ...